The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product, Moderna COVID-19 Vaccine, for active immunization to prevent COVID-19 in individuals 18 years of age and older.

SUMMARY OF INSTRUCTIONS FOR COVID-19 VACCINATION PROVIDERS

Vaccination providers enrolled in the federal COVID-19 Vaccination Program must report all vaccine administration errors, all serious adverse events, cases of Multisystem Inflammatory Syndrome (MIS) in adults, and cases of COVID-19 that result in hospitalization or death following administration of the Moderna COVID-19 Vaccine. See “MANDATORY REQUIREMENTS FOR Moderna COVID-19 Vaccine ADMINISTRATION UNDER EMERGENCY USE AUTHORIZATION” for reporting requirements.

Moderna COVID-19 Vaccine – FDA prescribing information, side effects and uses

The only problem was that only about 1 percent of vaccine caused injuries, hospitalizations and deaths were reported. Most of them were covered up, denied, suppressed, ignored, or hidden.